Activation of Progelatinase B (MMP-9) by Gelatinase A (MMP-2)

Cancer Research

Volumn 55, Issue 12, 1995, Pages 2548-2555

  Fridman, Rafael ^a   Toth, Marta ^a   Peña, Daniel ^a   Mobashery, Shahriar ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENYLMERCURIC ACETATE; ENZYME PRECURSOR; GELATINASE; GELATINASE A; METALLOPROTEINASE INHIBITOR; PROGELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; CELL MEMBRANE; COLLAGENASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; GELATINASE A; GELATINASE B; GELATINASES; GLYCOPROTEINS; HELA CELLS; HUMAN; KINETICS; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PROTEINS; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, NON-P.H.S.; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE INHIBITOR-OF METALLOPROTEINASE-2;

EID: 0029034457     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Liotta, L. A., Steeg, P. A., and Stctler-Stcvenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327–336, 1991.
2. Matrisian, L. M. Metalloproteinases and their inhibitors in tissue remodelling. Trends Genet., 6: 121–125, 1990.
3. Testa, J. E., and Quigley, J. P. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev., 9: 353–367, 1990.
4. Sloane, B. F., Moin, K., and Lah, T. T. Regulation of lysosomal endopeptidases in malignant neoplasia. In: T. G. Pretlow and T. P. Pretlow (eds.), Biochemical and Molecular Aspects of Selected Cancers, Vol. 2, pp. 411–466. New York: Academic Press, 1994.
5. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C., Bauer, E. A., and Goldberg, G. I. H-ras oncogene-trans-formed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem., 263:6579–6587, 1988.
6. Wilhelm, S. M., Collier, I. E., Manner, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264: 17213–17221, 1989.
7. Stetler-Stevenson, W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9: 289–303, 1990.
8. d'Errico, A., Garbisa, S., Liotta, L. A., Castranovo, V., Stetler-Stevenson, W. G., and Grigioni, W. F. Augmentation of type IV collagenase, laminin receptor and Ki62 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod. Pathol., 4: 239–246, 1991.
9. Poulsom, R., Hanby, A. M., Pignatelli, M., Jeffrey, R. E., Longcroft, J. M., Rogers, L., and Stamp, G. W. Expression of gelatinase A and TIMP-2 mRNAs in desmo-plastic fibroblasts in both mammary carcinomas and basal cell carcinomas. J. Clin. Pathol., 46: 429–436, 1993.
10. Pyke, C., Ralfkiaer, E., Tryggvason, K., and Dano, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142: 359–365, 1993.
11. Poulsom, R., Pignatelli, M., Stetler-Stevenson, W. G., Liotta, L. A., Wright, P. A., Jeffrey, R. E., Longcroft, J. A., Rogers, L., and Stamp, G. W. H. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol., 141: 389–396, 1992.
12. Autio-Harmainen, H., Karttunen, T., Hurskainen, T., Hoyhtya, M., Kauppila, A., and Tryggvason, K. Expression of 72 kDa type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab. Invest., 69: 312–321, 1993.
13. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 53: 140–146, 1993.
14. Davies, B., Waxman, J., Wasan, H., Abel, P., Williams, G., Krausz, T., Neal, D., Thomas, D., Hanby, A., and Balkwill, F. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53: 5365–5369,1993.
15. Fessler, L., Duncan, K., and Tryggvason, K. Identification of the procollagen IV cleavage products produced by a specific tumor collagenase. J. Biol. Chem., 259: 9783–9789, 1984.
16. Woessner, J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J., 5: 2145–2154, 1991.
17. Senior, R. M., Griffin, G. L., Fliszar, C. J., Shapiro, S. D., Goldberg, G. I., and Welgus, H. G. Human 92- and 72 kilodalton type IV collagenases are elastases. J. Biol. Chem., 266: 7870–7875, 1991.
18. Murphy, G., Cockett, M. I., Ward, R. V., and Docherty, A. J. Matrix metalloprotein-ase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J., 277: 277–279, 1991.
19. Nguyen, Q., Murphy, G., Hughes, C. E., Mort, J. S., and Roughley, P. J. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem. J., 295: 595–598, 1993.
20. Fosang, A. J., Last, K., Knauper, V., Neame, P. J., Murphy, G., Hardingham, T. E., Tschesche, H., and Hamilton, J. A. Fibroblast and neutrophil collagenases cleave at two distinct sites in the cartilage aggrecan interglobular domain. Biochem. J., 295: 273–276, 1993.
21. Sires, U. I., Griffin, G. L., Broekelman, T. J., Mecham, R. P., Murphy, G., Chung, A. E., Welgus, H. G., and Senior, R. M. Degradation of entactin by matrix metalloproteinases: susceptibility to matrilysin and identification of cleavage sites. J. Biol. Chem., 268: 2069–2074, 1993.
22. Miyazaki, K., Hasegawa, M., Funahashi, K., and Umeda, M. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature (Lond.), 362: 839–841, 1993.
23. Roher, A. E., Kasunic, T. C., Woods, A. S., Cotter, R. J., Ball, M. J., and Fridman, R. Proteolysis of A/β peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun., 205: 1755–1761, 1994.
24. Ochieng, J., Fridman, R., Nangia-Makker, P., Liotta, L. A., Stetler-Stevenson, W. G., and Raz, A. Galectin-3 is a novel substrate for human matrix metalloproteinases 2 and 9. Biochemistry, 33: 14109–14114, 1994.
25. Ward, R. V., Atkinson, S. J., Slocombe, P. M., Docherty, A. J. P., Reynolds, J. J., and Murphy, G. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblasts membranes. Biochim. Biophys. Acta, 1079: 242–246, 1991.
26. Brown, P. D., Kleiner, D. E., Unsworth, E. J., and Stetler-Stevenson, W. G. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int., 43: 163–170, 1993.
27. Strongin, A. Y., Manner, B. L., Grant, G. A., and Goldberg, G. I. Plasma membrane-dependent activation of the 72 kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268: 14033–14039, 1993.
28. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed in the surface of tumor cells. Nature (Lond.), 370: 61–65, 1994.
29. Overall, C. M., and Dodek, J. Concanavalin-A produces a matrix-degradative phe-notype in human fibroblasts. Induction/endogenous activation of collagenase, 72 kDa gelatinase and pump-1 is accompanied by suppression of tissue inhibitor of metalloproteinases. J. Biol. Chem., 265: 21141–21151, 1990.
30. Overall, C. M. Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann. NY Acad. Sci., 732: 51–64, 1994.
31. Azzam, H. S., and Thompson, E. W. Collagen-induced activation of 72,000 type IV collagenase in normal and malignant fibroblastoid cells. Cancer Res., 52: 4540–4544, 1992.
32. Fridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L. A., Berman, M. L., and Stetler-Stevenson, W. G. Domain structure of human 72-kDa gelatinase/type IV collagenase. J. Biol. Chem., 267: 15398–15405, 1992.
33. Fridman, R., Bird, R., Hoyhtya, M., Oelkuct, M., Komarek, D., Liang, C-M., Berman, M. L., Liotta, L. A., Stetler-Stevenson, W. G., and Fuerst, T. R. Expression of human recombinant 72 kDa gelatinasc/type IV collagenase and TIMP-2: characterization of complex and free enzyme. Biochem. J., 289: 411–416, 1993.
34. Goldberg, G. I., Manner, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. M., and He, C. Human 72-kilodalton type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2. Proc. Natl. Acad. Sci. USA, 86: 8207–8211, 1989.
35. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibitor of metalloproteinase-2 (TIMP-2). J. Biol. Chem., 264: 17374–17378, 1989.
36. Howard, E. W., and Banda, M. J. Binding of tissue inhibitor of metalloproteinases-2 to two distinct sites on human 72 kDa gelatinase. J. Biol. Chem., 266:17972–17977, 1991.
37. Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D., and Docherty, A. J. P. The C-terminal domain of 72 kDa gelatinase is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J., 283: 637–641, 1992.
38. Willenbrock, F., Crabbe, T., Slocombe, P. M., Sutton, C. W., Docherty, A. J. P., Cockett, M. I., O'Shea, M., Brocklehurst, K., Phillips, I. R., and Murphy, G. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry, 32: 4330–4337, 1993.
39. Ogata, Y., Enghild, J. J., and Nagase, H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem., 267: 3581–3584, 1992.
40. O'Connell, J. P., Willenbrock, F., Docherty, A. J. P., Eaton, D., and Murphy, G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity and tissue inhibitor of metalloproteinase interactions of gelatinase B. J. Biol. Chem., 269: 14967–14973, 1994.
41. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. J. Biol. Chem., 267: 21712–21719, 1992.
42. Menashi, S., Fridman, R., Desrevieres, S., Lu, H., Legrand, Y., and Soria, C. Regulation of 92-kDa gelatinase B activity in the extracellular matrix by tissue kallikrein. Ann. NY Acad. Sci., 732: 466–468, 1994.
43. Polette, M., Clavel, C., Cockett, M., Bentzmann, S. G., Murphy, G., and Birembaut, P. Detection and localization of mRNAs encoding matrix metalloproteinases and their inhibitors in human breast pathology. Invasion Metastasis, 13: 31–37, 1993.
44. Brown, P. D., Bloxidge, R. E., Anderson, E., And Howell, A. Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Metastasis, 11: 183–189, 1993.
45. Davies, B., Miles, D. W., Happerfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D., and Balkwill, F. R. Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67: 1126–1131, 1993.
46. Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C-M., Sarkar, F. H., Crissman, J. D., and Fridman, R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer, 59: 339–344, 1994.
47. Fuerst, T. M., Earl, P. L., and Moss, B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol., 7: 2538–2544,1987.
48. Howard, E. W., Bullen, E. G., and Banda, M. J. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J. Biol. Chem., 266: 13070–13075, 1991.
49. Heinrikson, L., and Meredith, S. C. Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothio-cyanato. Anal. Biochem., 136: 65–74, 1984.
50. Hoyhtya, M., Fridman, R., Komarek, D., Porter-Jordan, K., Stetler-Stevenson, W. G., Liotta, L. A., and Liang, C-M. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int. J. Cancer, 56: 500–505, 1994.
51. Kleiner, D. E., Tuuttila, A., Tryggvason, K., and Stetler-Stevenson, W. G. Stability analysis of latent and active 72-kDa type IV collagenase: the role of issue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry, 32: 1583–1592, 1993.
52. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res., 50: 6162–6170, 1990.
53. Kolkenbrock, H., Orgell, D., Hecker-Kia, A., Noack, W., and Ulbrich, N. The complex between a tissue inhibitor of metalloproteinases-2 (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem., 198: 775–781,1991.
54. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., and Manner, B. L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem., 267:4583–4591,1992.
55. Strongin, A. Y., Collier, I., Bannikov, G., Manner, B. L., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72 kDa type collagenase: isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270: 5331–5338, 1995.
56. Howard, E. W., Bullen, E. C., and Banda, M. J. Regulation of the autoactivation of human 72-kDa progelatinase by the tissue inhibitor of metalloproteinases-2. J. Biol. Chem., 266: 13064–13069, 1991.
57. Stetler-Stevenson, W. G., Krutzsch, H. C., Wacher, M. P., Margulies, I. M. K., and Liotta, L. A. The activation of human type IV collagenase proenzyme: sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem., 264: 1353–1356, 1989.
58. Fridman, R., Lacal, J. C., Reich, R., Bonfil, R. D., and Ann, C. Differential effect of phorbol ester on the in vitro invasiveness of malignant and non-malignant human fibroblast cells. J. Cell. Physiol., 142: 55–60, 1990.
59. Nguyen, Q., Willenbrock, F., Cockett, M. I., O'Shea, M., Docherty, A. J., and Murphy, G. Different domain interactions are involved in the binding of tissue inhibitor of metalloproteinases to stromelysin-1 and gelatinase A. Biochemistry, 33: 2089–2095, 1994.